CompletedPhase 4ketamine
Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy
Sponsored by Complexo Hospitalario Universitario de A Coruña
NCT ID
NCT02909049
Target Enrollment
100 participants
Start Date
2016-04
Est. Completion
2018-01-24
About This Study
To assess the effectiveness of two anesthetic techniques by measuring the pain through visual analog scale (VAS), to obtain saturation prostate biopsies.
Conditions Studied
Interventions
- •MIDAZOLAM
- •MEPIVACAÍNE
- •FENTANILE
- •KETAMINE
Eligibility
Sex:MALE
Age:18 Years - 75 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Male patient * Persistence of suspected prostate cancer by altering the prostatic specific antigen and / or digital rectal examination. * Two previous negative prostate biopsies . * Age \< 75 years. * Signature of informed consent to perform prostate biopsy. * Signature of informed consent for the study. Exclusion Criteria: * Age \> 75 years. * Absence of consent or refusal to the study . * Presence of prostate cancer in previous biopsy observation . * Medical-surgical patient's problems, absolutely contraindicating biopsy under local anesthesia. * Presence of any allergies to medications involved in the study . * Patient's clinical situation that does not allow an outpatient operation and aftercare required . * Medical condition of the patient, preventing the realization of outpatient biopsy. * No companion.
Study Locations (1)
Jose Luis Ponce Diaz-Reixa
A Coruña, Spain